Mefcom Capital Markets Other Announcement

Mefcom Capital Markets Board Meeting Date

Mefcom Capital Markets scheduled its board meeting for 04 November 2026 to approve Q2 FY27 standalone and consolidated results. No financial figures or decisions are reported in this advance intimation.

Mefcom Capital Markets Other Announcement

Mefcom Capital Markets Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.

Mefcom Capital Markets Merger & Restructuring Worth ₹2.58 Cr

Mefcom Capital Markets sold its entire stake in subsidiary Mefcom Securities to its promoter, Vijay Mehta, for ₹2.58 Crore.

Value

₹2.58 Cr

Mefcom Capital Markets Promoter Selling (Off-Market)

Karan Mehta (promoter) transferred 20,00,000 shares (4.38% stake) to Priyanka Mehta via an off-market gift deed. This inter-se transfer reallocates promoter group equity.

Mefcom Capital Markets Promoter Buying (Off-Market)

Promoter Priyanka Mehta received 20,00,000 Mefcom Capital Markets shares from relative Karan Mehta via gift deed. The off-market transfer raised her stake to 4.41% with no cash.

Promoter stake change

+4.37%

Mefcom Capital Markets Q1 FY27 Results: Net Profit ₹7.2 Cr, Up 41.2% YoY

Mefcom Capital Markets Ltd reported revenue from operations of ₹50 Cr (+2.0% YoY) and net profit of ₹7.2 Cr (+41.2% YoY) for Q1 FY27.

Key figure

Net profit ₹7.2 Cr · +41.2% YoY

Mahindra & Mahindra Financial Services Other Announcement

Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.

ACME Solar Holdings Other Announcement

ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.

eMudhra Other Announcement

eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.

Aarti Pharmalabs Other Announcement

Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.

Sagarsoft (India) Other Announcement

Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.

Sadhana Nitro Chem Other Announcement

Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.